Company · CIK 1842295

# Maze Therapeutics, Inc.

| CIK | [1842295](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001842295) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | MAZE (Nasdaq) |
| First annual or quarterly report | 2025-03-31 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-290935 | Registered company Effective | 2025-10-17 | 2026-05-13 | 2 |
| 333-293206 | Shelf Effective | 2026-02-04 | 2026-04-22 | 2 |
| 333-284164 | IPO Final prospectus | 2025-01-07 | 2025-01-31 | 5 |

## Filings

 10

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-05-13 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1842295/999999999526001606/9999999995-26-001606-index.htm) Declared effective | 333-290935 | 9999999995-26-001606 |
| 2026-04-22 | [424B5](https://www.sec.gov/Archives/edgar/data/1842295/000119312526170687/0001193125-26-170687-index.htm) Shelf takedown | 333-293206 | 0001193125-26-170687 |
| 2026-02-04 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1842295/000119312526037831/0001193125-26-037831-index.htm) Shelf registered | 333-293206 | 0001193125-26-037831 |
| 2025-10-17 | [S-1](https://www.sec.gov/Archives/edgar/data/1842295/000119312525242526/0001193125-25-242526-index.htm) Registration filed | 333-290935 | 0001193125-25-242526 |
| 2025-01-31 | [424B4](https://www.sec.gov/Archives/edgar/data/1842295/000119312525018482/0001193125-25-018482-index.htm) Final prospectus | 333-284164 | 0001193125-25-018482 |
| 2025-01-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1842295/999999999525000242/9999999995-25-000242-index.htm) Declared effective | 333-284164 | 9999999995-25-000242 |
| 2025-01-30 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1842295/000119312525016039/0001193125-25-016039-index.htm) Amendment | 333-284164 | 0001193125-25-016039 |
| 2025-01-27 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1842295/000119312525012638/0001193125-25-012638-index.htm) Amendment | 333-284164 | 0001193125-25-012638 |
| 2025-01-07 | [S-1](https://www.sec.gov/Archives/edgar/data/1842295/000119312525002851/0001193125-25-002851-index.htm) Registration filed | 333-284164 | 0001193125-25-002851 |
| 2024-06-21 | [DRS](https://www.sec.gov/Archives/edgar/data/1842295/000095012324006286/0000950123-24-006286-index.htm) Draft made public | 377-07295 | 0000950123-24-006286 |

[All filings of this company](https://equitycapital.markets/filings?cik=1842295) · [CSV](https://equitycapital.markets/filings.csv?cik=1842295)

---
Source page: https://equitycapital.markets/company/1842295 · Data: U.S. SEC EDGAR · CC BY 4.0